 Press Release Distribution |
 |
vaccine News+ XML/RSSBy Jonathan Joel Regulatory Officials recently made huge advances in Artificial Immune Function Technology Transitions for Assessing Vaccine and Biothreats Efficacy; whereby Knight Officials considered the legislative impact. By Fast Market Research New Pharmaceuticals market report from GlobalData: "Hepatitis B Vaccines - Pipeline Assessment and Market Forecasts to 2017" By Danny Aronovic BiondVax Pharmaceuticals Ltd., an Israeli biopharmaceutical company developing a Universal Influenza Vaccine, today announced that it has raised $1.25 million under its Standby Equity Distribution Agreement (SEDA) with YA Global Investments L.P. By Danny Aronovic Dr. Tamar Ben-Yedidia will be presenting at the Influenza Congress USA next week in Washington, D.C. BiondVax is currently in Phase IIa clinical trials (human subjects) for its Universal Influenza Vaccine. By Rajesh Gunnam The Prostate Cancer Therapeutics Market was Driven by the Growth in Patient Volume and Annual Cost of Hormone-refractory Prostate Cancer Therapy By Miles for Hope Miles For Hope, a Clearwater charity, will be the recipient of proceeds from a fundraising challenge set to raise critically needed awareness and funding of brain tumors By Kalorama Information Breast cancer accounts for approximately 12% of all cancers worldwide. In the U.S. more than 200,000 people develop breast cancer each year, with more than 95% of these women. By Bharatbook Bharatbook added a new report on "Global Vaccine Market Forecast to 2012" which gives extensive research and objective analysis of the vaccine market in key countries of the world. By RNCOS. By Danny Aronovic Dr. Tamar Ben-Yedidia will be speaking at the upcoming World Vaccine Congress in Lyon, France on October 4, 2010. She will be updating the congress on the company's progress and upcoming Phase II trials starting in October. By ResearchInChina ResearchInChina, the vertical portal for Chinese business intelligence, announces the release of a new report - China Vaccine Industry Report, 2009-2010. For more information, please contact us at report@researchinchina.com or at 86-10-82600828. By Pirages Communications for Jewel-Osco To meet the demand for this year's flu season, specially trained and certified JEWEL-OSCO pharmacists are available to administer the flu vaccine at nearly all JEWEL-OSCO pharmacies. By Kalorama Information Drug delivery has become an important focus of the industry. Biopharmaceutical products are driving growth of needle-free systems; there will likely be significant increases in revenues in the vaccine arena. By Mark Warne The FDA is to assess the feasibility of Glythera technology in developing antigenic glycoproteins as synthetic conjugate vaccines. By Miles for Hope Miles for Hope, a Clearwater charity, will be the recipient of proceeds from a charity pool tournament to raise brain tumor awareness and funding for a brain tumor vaccine clinical trial By Pirages Communications for Jewel-Osco Every year, at least 1 million people in the United States develop the painful skin rash shingles. JEWEL-OSCO is offering shingles vaccinations at all of its in-store pharmacies. BiondVax Announces Approvals for Initiation of First Phase II Trials for Universal Influenza Vaccine By Danny Aronovic BiondVax Announces Receipt of Ethics (“Helsinki”) Committee Approvals for the Initiation of first Phase II Clinical Trial for Universal Influenza Vaccine By Miles for Hope Miles for Hope seeks to raise $ 250,000 to open the first clinical trial for custom life-saving cancer vaccine for pediatric patients and adults with low-grade brain cancer By Danny Aronovic According to Frost & Sullivan, BiondVax is the leading company in the quest for the universal influenza vaccine and has received Frost & Sullivan’s 2010 European Influenza Vaccines Technology Innovation Award. By Fast Market Research New Healthcare research report from Datamonitor is now available from Fast Market Research By Aarkstore Enterprise Aarkstore announce a new report "H1N1 "Swine Flu" Vaccine Market Review (Revenues, Forecasts, Lessons for Future Pandemic Vaccines)" through its vast collection of market reserach report. By Imapac Pte Ltd BioManufacturing World and Vaccine manufacturing World Events are co-located events that will be held in Shanghai, China in Oct 2010. By 168REPORT 2010 Report on China Animal Vaccine Industry By Dan Aronovic Chief Scientific Officer, Dr. Tamar Ben Yedidia, will provide an overview of the Company's technology and clinical development progress at two upcoming biopharma industry conferences in Israel and Barcelona, Spain By Fast Market Research New Healthcare market report from Business Monitor International: "Bangladesh Pharmaceuticals & Healthcare Report Q3 2010" By Fast Market Research Fast Market Research recommends "Netherlands Pharmaceuticals & Healthcare Report Q3 2010" from Business Monitor International, now available By CCM International Limited Biopharmaceuticals China News is a monthly report with 12 issues per annum published by CCM International Limited. It's your gateway to know latest news like Investment Focus, Governmental Policies,Market Dynamics,and Technology & New Products,etc. By Bharatbook Bharatbook added a new report on "H1N1 Swine Flu Vaccine Market Review (Revenues, Forecasts, Lessons for Future Pandemic Vaccines)" into its market report catalogue for reselling. By Fast Market Research Recently published research from GlobalData, "Tuberculosis - Drug Pipeline Analysis and Market Forecasts to 2016", is now available at Fast Market Research By Fast Market Research New Pharmaceuticals research report from Business Insights is now available from Fast Market Research By PRStreet, Inc. Club to Raise Polio Awareness in Downtown Apex By Mark Vander Hoff Noesys Data has been selected by The Transformational Medical Technologies Initiative (TMTI) Program Office to present a capability brief to TMTI Performers at the upcoming TMTI Partnership Symposium May 3-4 2010. By Charak Clinics Yellow Fever Vaccine Available for North India, Punjab, Chandigarh, Haryana, Himachal, J & K, UP at By Fast Market Research Fast Market Research recommends "Japan Pharmaceuticals & Healthcare Report Q2 2010" from Business Monitor International, now available By Dan Aronovic BiondVax Reports Positive Interim Safety Results from Second Phase I/II Universal Influenza Vaccine Trial BiondVax’s Multimeric-001 Universal Flu Vaccine Shown to be Safe and Well Tolerated in trial of 60 elderly participants By Fast Market Research Recently published research from Business Monitor International, "Uzbekistan Pharmaceuticals & Healthcare Report Q2 2010", is now available at Fast Market Research By Fast Market Research New Healthcare market report from Business Monitor International: "Bangladesh Pharmaceuticals & Healthcare Report Q2 2010" By Tom Bionic Surgeon and radio show host stan monteith exposes the deadly and hidden legacy of our immunization and public health policies, on the 22 - 26 feb 10 “future quake” radio programs By daisywright As the death ratio of females due to cervical cancer was getting above from par, experts and researchers came up with the solution in the form of a vaccination that can contribute in reducing the ratio to the least. Over a period of time. By reports-research.com “A strong domestic vaccine industry is available for partnerships in India, China and Korea. However, market access remains challenging in some countries, with local expertise being vital for commercial success.” By Bharatbook Bharatbook.com added a new report on "Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015" which gives current and future market competition in the global hepatitis B vaccines market. By Nivetha The first H1N1 Influenza Vaccine trial testing a candidate 2009 H1N1 influenza vaccine in pregnant lady is launching this week. By Bharat Book Bureau Bharatbook.com added a new report on " The Future of Global Vaccines - Market Forecasts to 2016, Stockpile Analysis, Competitive Benchmarking and Pipeline Analysis " which provides the global vaccines sales, volume and price forecasts to 2015. By Westside Preventive Medicine Westside Preventive Medicine has just received one of the Los Angeles area’s first shipments of the H1N1 flu vaccines. And unlike most mini-clinics and pharmacies, a doctor will administer the vaccines offered at Westside Preventive Medicine. By MommyMDGuides.com Find out how an emergency room physician, disaster medical director, and mom of three protects her kids from H1N1. By Fast Market Research Fast Market Research recommends "Thailand Pharmaceuticals & Healthcare Report Q1 2010" from Business Monitor International, now available By Bharatbook Bharatbook.com included a new report on "Global Vaccine Market Forecast to 2012" which gives an extensive and objective analysis on the global vaccine market. By Jason Principe School battles the flu with lotus chemical-free cleaning technology. By MomentumStockPick.com Hot Biotech Stock Picks > Cheap Pharmaceutical Hot Stocks at MomentumStockPick.com By MomentumStockPick.com Hot Stock Picks > Cheap Top Stocks at MomentumStockPick.com Asthmatics at Severe Risk for Flu, H1N1 - Vaccination urged by American Lung Assn in Greater Chicago By American Lung Association in Greater Chicago New CDC Report States 32% of 2009 H1N1 Hospitalizations Were Asthmatics |
Like PRLog?
3.5K1.4K1.3K